Association of lymphocyte sub-populations with clustered features of metabolic syndrome in middle-aged Japanese men

Atherosclerosis

Volumn 173, Issue 2, 2004, Pages 295-300

  Tanigawa, Takeshi ^a   Iso, Hiroyasu ^a   Yamagishi, Kazumasa ^a   Muraki, Isao ^a   Kawamura, Noriyuki ^b   Nakata, Akinori ^c   Sakurai, Susumu ^d   Ohira, Tetsuya ^e   Shimamoto, Takashi ^e  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^c NATL INSTITUTE OF INDUSTRIAL HEALTH   (Japan)

^d UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^e OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

Atherosclerosis; CD4+CD45RO+T cells; Differential leukocyte counts; Lymphocyte subsets; Memory T cells; Metabolic syndrome

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CELLULAR IMMUNITY; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; GLUCOSE BLOOD LEVEL; HUMAN; JAPAN; LEUKOCYTE COUNT; LIPOPROTEIN BLOOD LEVEL; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PATHOGENESIS; PRIORITY JOURNAL; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE DETERMINATION; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CLUSTER ANALYSIS; COHORT STUDIES; HUMANS; JAPAN; LYMPHOCYTE COUNT; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROBABILITY; RISK FACTORS; SENSITIVITY AND SPECIFICITY; T-LYMPHOCYTE SUBSETS; TRIGLYCERIDES;

EID: 1842716902     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2003.12.019     Document Type: Article

References (32)

1. Ross R. Atherosclerosis: an inflammatory disease. N. Engl. J. Med. 340:1999;115-126.
2. Hansson G.K. Immune mechanisms in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 21:2001;1876-1890.
3. Lind L. Circulating markers of inflammation and atherosclerosis. Atherosclerosis. 169:2003;203-214.
4. Danesh J., Collins R., Appleby P., Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. J. Am. Med. Assoc. 279:1998;1477-1482.
5. Hoffman M, Blum A, Baruch R, Kaplan E, Benjamin M. Leukocytes and coronary heart disease. Atherosclerosis 2004;172:1-6.
6. Ble A., Palmieri E., Volpato S., Costantini F., Fellin R., Zuliani G. White blood cell count is associated with some features of metabolic syndrome in a very old population. Nutr. Metab. Cardiovasc. Dis. 11:2001;221-226.
7. Nakanishi N., Suzuki K., Tatara K. White blood cell count and clustered features of metabolic syndrome in Japanese male office workers. Occup. Med. (Lond.). 52:2002;213-218.
8. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the NCEP expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). J Am Med Assoc 2001;285:2486-97.
9. Bonora E., Kiechl S., Willeit J., Oberhollenzer F., Egger G., Bonadonna R.C.et al. Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study. Diabetes Care. 26:2003;1251-1257.
10. Lakka H.M., Laaksonen D.E., Lakka T.A.et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. J. Am. Med. Assoc. 288:2002;2709-2716.
11. Onat A., Ceyhan K., Basar O., Erer B., Toprak S., Sansoy V. Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels: a prospective and cross-sectional evaluation. Atherosclerosis. 165:2002;285-292.
12. Tanigawa T, Kitamura A, Yamagishi K, et al. Relationships of differential leukocyte and lymphocyte sub-populations with carotid atherosclerosis in elderly men. J Clin Immnunol 2003;23:469-76.
13. Lean M.E., Han T.S., Morrison C.E. Waist circumference as a measure for indicating need for weight management. Br. Med. J. 311:1995;158-161.
14. Sanders M.E., Makgoba M.W., Shaw S. Human naive and memory T in healthy subjects. Met cells: reinterpretation of helper-inducer and suppressor-inducer subsets. Immunol. Today. 9:1988;195-199.
15. Nieman D.C., Henson D.A., Nehlsen-Cannarella S.L.et al. Influence of obesity on immune function. J. Am. Diet Assoc. 99:1999;294-299.
16. Gillum R.F., Mussolino M.E. White blood cell count and hypertension incidence. The NHANES I Epidemiologic Follow-up Study. J. Clin. Epidemiol. 47:1994;911-919.
17. Van Oostrom A.J., Sijmonsma T.P., Rabelink T.J., Van Asbeck B.S., Cabezas M.C. Postprandial leukocyte increase abolism. 52:2003;199-202.
18. Targher G., Seidell J.C., Tonoli M., Muggeo M., De Sandre G., Cigolini M. The white blood cell count: its relationship to plasma insulin and other cardiovascular risk factors in healthy male individuals. J. Intern. Med. 239:1996;435-441.
19. Festa A., D'Agostino R. Jr., Howard G., Mykkanen L., Tracy R.P., Haffner S.M. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 102:2000;42-47.
20. Stemme S., Holm J., Hansson G.K. T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1. Arterioscler. Thromb. 12:1992;206-211.
21. Zhou X, Nicoletti A, Elhage R, Hansson GK. Transfer of CD4+ T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation 2000;102:2919-22.
22. Frostegard J., Ulfgren A.K., Nyberg P.et al. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis. 145:1999;33-43.
23. Benagiano M., Azzurri A., Ciervo A.et al. T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions. Proc. Natl. Acad. Sci. U.S.A. 100:2003;6658-6663.
24. Feldman D.L., Mogelesky T.C., Liptak B.F., Gerrity R.G. Leukocytosis in rabbits with diet-induced atherosclerosis. Arterioscler. Thromb. 11:1991;985-994.
25. Elkind M.S., Cheng J., Boden-Albala B., Paik M.C., Sacco R.L. Elevated white blood cell count and carotid plaque thickness: the northern Manhattan stroke study. Stroke. 32:2001;842-849.
26. Freedman D.S., Flanders W.D., Barboriak J.J., Malarcher A.M., Gates L. Cigarette smoking and leukocyte sub-populations in men. Ann. Epidemiol. 6:1996;299-306.
27. Smith M.R., Kinmonth A.L., Luben R.N.et al. Smoking status and differential white cell count in men and women in the EPIC-Norfolk population. Atherosclerosis. 169:2003;331-337.
28. Tollerud D.J., Clark J.W., Brown L.M.et al. The effects of cigarette smoking on T cell subsets. A population-based survey of healthy caucasians. Am. Rev. Respir. Dis. 139:1989;1446-1451.
29. Chavance M., Perrot J.Y., Annesi I. Smoking, CD45RO+ (memory), and CD45RA+ (naive) CD4+ T cells. Am. Rev. Respir. Dis. 148:1993;237-240.
30. Tanigawa T., Araki S., Nakata A., Kitamura F., Yasumoto M., Sakurai S. Increase in memory (CD4+CD29+ and CD4+CD45RO+T) and naïve (CD4+CD45RA+T) cell sub-populations in smokers. Arch. Environ. Health. 53:1998;378-383.
31. Francus T., Klein R.F., Staiano-Coico L., Becker C.G., Siskind G.W. Effects of tobacco glycoprotein (TGP) on the immune system. II. TGP stimulates the proliferation of human T cells and the differentiation of human B cells into Ig secreting cells. J. Immunol. 140:1988;1823-1829.
32. McCarty M.F. Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: down-regulation with essential fatty acids, ethanol and pentoxifylline. Med. Hypotheses. 52:1999;465-477.